VANCOUVER, Feb. 5 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today for the year ended December 31, 2007, it had 13,461 patient visits at
its Centers for Colorectal Health compared to 1,699 patient visits for the
same period in 2006.
Commenting on this achievement, Edward Wright, CEO of CRH Medical
Corporation stated, "In 2007, we demonstrated the strong demand for the
CRH O'Regan hemorrhoid banding technology and treatment protocol. In 2008, we
plan to open several additional Centers in new markets throughout the United
States allowing CRH to further capitalize on this large and underserved
market. According to the National Institutes of Health the prevalence rate of
symptomatic hemorrhoids in the United States is approximately 4.4% of the
population or 13.3 million people."
Centers open one year or longer continue to show strong growth, with
patient visits increasing 485% for the three months ended December 31, 2007
compared to the same period in 2006.
Commenting on the CRH O'Regan Hemorrhoid Banding technology and treatment
protocol, Dr. Iain Cleator, Chief Medical Director of CRH said, "The most
important aspect of our technology and treatment protocol is that we are
experiencing the same excellent results in each of our Centers. This means
that our training methodology and treatment protocol is transferable and
Dr. Carolyn Million, Medical Director of CRH's San Francisco Center,
added, "As a Fellow of the American Society of Colon and Rectal Surgeons I
have treated hemorrhoids for 15 years. In my opinion the CRH O'Regan banding
technology and treatment protocol consistently provide a significantly higher
level of patient satisfaction compared with other hemorrhoid treatments
About CRH Medical Corporation:
CRH Medical Corporation is utilizing the first single use, patented,
disposable, hemorrhoid banding system through its Center for Colorectal Health
facilities. According to the National Institute of Health approximately 50% of
the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening
its Center for Colorectal Health facilities in the United States specializing
in the treatment of hemorrhoids and fissures, and colon cancer screening and
plans to significantly increase the number of Centers for Colorectal Health
across the U.S. to address this underserved market. The Company's goal is to
become the preeminent resource on colorectal health for consumers and medical
professionals in North America.
The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical expectations,
beliefs, intentions or strategies for the future, which may be indicated by
words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we
believe", "CRH Medical believes", "management believes" and similar language.
All forward-looking statements are based on CRH Medical current expectations
and are subject to risks and uncertainties and to assumptions made.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
For further information:
For further information: Dean Linden, Investor Relations, CRH Medical
Corporation at (604) 633-1440, or email@example.com; Additional information
may also be found by visiting the Company's website at www.crhmedcorp.com, or
the SEDAR website at www.sedar.com